NO982294D0 - Farmas÷ytiske blandinger omfattende flurbiprofen - Google Patents

Farmas÷ytiske blandinger omfattende flurbiprofen

Info

Publication number
NO982294D0
NO982294D0 NO982294A NO982294A NO982294D0 NO 982294 D0 NO982294 D0 NO 982294D0 NO 982294 A NO982294 A NO 982294A NO 982294 A NO982294 A NO 982294A NO 982294 D0 NO982294 D0 NO 982294D0
Authority
NO
Norway
Prior art keywords
flurbiprofen
pharmaceutical
surface mixtures
mixtures
sugar
Prior art date
Application number
NO982294A
Other languages
English (en)
Other versions
NO982294L (no
NO317287B1 (no
Inventor
David Michael Barrett
Carl Simon Smith
David Michael Thurgood
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO982294D0 publication Critical patent/NO982294D0/no
Publication of NO982294L publication Critical patent/NO982294L/no
Publication of NO317287B1 publication Critical patent/NO317287B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19982294A 1995-11-22 1998-05-20 Farmasoytiske blandinger omfattende flurbiprofen NO317287B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (3)

Publication Number Publication Date
NO982294D0 true NO982294D0 (no) 1998-05-20
NO982294L NO982294L (no) 1998-07-20
NO317287B1 NO317287B1 (no) 2004-10-04

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982294A NO317287B1 (no) 1995-11-22 1998-05-20 Farmasoytiske blandinger omfattende flurbiprofen

Country Status (21)

Country Link
US (2) US5889057A (no)
EP (1) EP0862424B1 (no)
CN (1) CN1148177C (no)
AT (1) ATE252382T1 (no)
AU (1) AU707749B2 (no)
BG (1) BG64166B1 (no)
CA (1) CA2238271C (no)
CZ (1) CZ289643B6 (no)
DE (1) DE69630460T2 (no)
DK (1) DK0862424T3 (no)
ES (1) ES2208768T3 (no)
GB (1) GB9523833D0 (no)
HU (1) HU225235B1 (no)
IL (1) IL124568A0 (no)
NO (1) NO317287B1 (no)
NZ (1) NZ322933A (no)
PT (1) PT862424E (no)
RU (1) RU2203655C2 (no)
SK (1) SK284092B6 (no)
UA (1) UA46807C2 (no)
WO (1) WO1997018802A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
JP2005509002A (ja) * 2001-11-13 2005-04-07 ファルマシア コーポレイション スルホンアミドプロドラックの経口剤形
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
MXPA05001267A (es) * 2002-08-01 2005-10-18 Aesgen Inc Tratamiento mejorado de cancer con glutamina.
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
KR101709904B1 (ko) 2009-05-19 2017-02-23 뉴로덤 엘티디 Dopa 데카르복실라제 억제제의 연속투여용 조성물
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
HUE047841T2 (hu) * 2010-11-15 2020-05-28 Neuroderm Ltd L-dopa, dopa dekarboxiláz inhibitorok, katekol-o-metil transzferáz inhibitorok folyamatos adagolására szolgáló készítmények
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
TR201903492T4 (tr) 2012-06-05 2019-04-22 Neuroderm Ltd Apomorfin ve organik asitler içeren bileşimler ve bunların kullanım alanları.
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
HUE064818T2 (hu) 2014-03-13 2024-04-28 Neuroderm Ltd Dopa dekarboxiláz inhibitor készítmények
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
CN118125916A (zh) * 2022-09-23 2024-06-04 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
ZA869433B (en) * 1985-12-16 1988-07-27 Cilag Ag Non-irritating suprofen solution
EP0321505A1 (en) * 1986-10-22 1989-06-28 The Upjohn Company Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
ATE117892T1 (de) * 1989-08-17 1995-02-15 Sepracor Inc Orales s(+)-flurbiprofen- oder ketoprofenhaltiges mittel.
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
AU685741B2 (en) * 1992-12-04 1998-01-29 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
WO1994014476A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
HUT76798A (en) * 1994-09-02 1997-11-28 Univ Virginia Commonwealth Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
AU6276996A (en) * 1995-07-05 1997-02-05 Procter & Gamble Company, The Warming compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
PT910339E (pt) * 1996-04-12 2005-05-31 Novadel Pharma Inc Aerossol polar bucal

Also Published As

Publication number Publication date
DE69630460D1 (de) 2003-11-27
CN1148177C (zh) 2004-05-05
CA2238271A1 (en) 1997-05-29
AU2611997A (en) 1997-06-11
EP0862424B1 (en) 2003-10-22
RU2203655C2 (ru) 2003-05-10
ES2208768T3 (es) 2004-06-16
SK284092B6 (sk) 2004-09-08
EP0862424A1 (en) 1998-09-09
DK0862424T3 (da) 2003-12-29
AU707749B2 (en) 1999-07-22
NO982294L (no) 1998-07-20
CZ156598A3 (cs) 1998-08-12
SK66598A3 (en) 1998-12-02
HU225235B1 (en) 2006-08-28
BG64166B1 (bg) 2004-03-31
CN1207677A (zh) 1999-02-10
PT862424E (pt) 2004-02-27
GB9523833D0 (en) 1996-01-24
WO1997018802A1 (en) 1997-05-29
NO317287B1 (no) 2004-10-04
HUP0000180A3 (en) 2001-10-29
ATE252382T1 (de) 2003-11-15
HUP0000180A2 (hu) 2000-08-28
UA46807C2 (uk) 2002-06-17
BG102526A (en) 1999-02-26
US5889057A (en) 1999-03-30
CA2238271C (en) 2008-08-12
IL124568A0 (en) 1998-12-06
CZ289643B6 (cs) 2002-03-13
NZ322933A (en) 2000-02-28
DE69630460T2 (de) 2004-08-19
US6166083A (en) 2000-12-26

Similar Documents

Publication Publication Date Title
NO982294D0 (no) Farmas÷ytiske blandinger omfattende flurbiprofen
ATE305301T1 (de) Mittel zur hemmung von angiogenese enthaltend thalodomid und einen nsaid
KR970702736A (ko) 비강용 투약기(Medicine Administering Device for Nasal Cavities)
DK398587D0 (da) Antitumorvirksomt laegemiddel
ATE97570T1 (de) Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.
KR950700754A (ko) 신규의 약물(novel medicament)
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
DK0776229T3 (da) Brusedyse
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
TR199901853T2 (xx) Gastrointestinal lipaz inhibit�r�n�n kullan�lmas�.
ITRM920869A0 (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
DE3860201D1 (de) Entzuendungshemmende agentien.
DK0624374T3 (da) Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati
ATE360428T1 (de) Analgetisches arzneimittel
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
PT806957E (pt) Terapeutica de construcao para infeccao por hiv utilizando o inibidor de protease de hiv indinavir e o inibidor de transcriptase reversa 3tc
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
DE68906513D1 (de) Topisch anzuwendende diclofenac enthaltende arzneizubereitungen.
ATE239739T1 (de) Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DK89489D0 (da) Anvendelse af halogenerede allylaminer til fremstilling af et farmaceutisk praeparat
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
DE3853551D1 (de) Plasmabehandlungsvorrichtung.
DK1237552T3 (da) Kombination af lumilysergol og riluzol for forebyggelse og/eller behandling af motorisk neuron-sygdomme

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees